Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Neutral

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Aziyo Biologics, Inc. Class A Common Stock (AZYO)

https://www.aziyo.com

Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health, Orthobiologics, and Cardiovascular. It generates maximum revenue from the Orthobiologics segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/08/2020

Market Cap

24,212,202

Shares Outstanding

11,940,000

Weighted SO

16,249,847

Total Employees

N/A

Upcoming Earnings

N/A

Beta

-0.0846

Last Div

0.0000

Range

1.1-9.01

Chg

0.0300

Avg Vol

432734

Mkt Cap

24212202

Exch

NASDAQ

Country

US

Phone

240 247 1170

DCF Diff

N/A

DCF

0.0000

Div Yield

0.0000

P/S

0.5746

EV Multiple

-2.1133

P/FV

-0.8603

Div Yield %

0.0000

P/E

-0.7506

PEG

-0.0075

Payout

0.0000

Current Ratio

0.8746

Quick Ratio

0.3889

Cash Ratio

0.3245

DSO

24.9726

DIO

87.9370

Op Cycle

112.9096

DPO

40.0537

CCC

72.8559

Gross Margin

0.3594

Op Margin

-0.6292

Pretax Margin

-0.7717

Net Margin

-0.8017

Eff Tax Rate

-0.0010

ROA

-0.6189

ROE

1.9638

ROCE

-2.6934

NI/EBT

1.0388

EBT/EBIT

1.2265

EBIT/Rev

-0.6292

Debt Ratio

0.5707

D/E

-1.0568

LT Debt/Cap

24.0980

Total Debt/Cap

18.5958

Int Coverage

-4.3630

CF/Debt

-0.4210

Equity Multi

-1.8519

Rec Turnover

14.6160

Pay Turnover

9.1128

Inv Turnover

4.1507

FA Turnover

127.6909

Asset Turnover

0.7720

OCF/Share

-0.7705

FCF/Share

-0.7941

Cash/Share

0.8531

OCF/Sales

-0.3112

FCF/OCF

1.0306

CF Coverage

-0.4210

ST Coverage

-32.8622

CapEx Coverage

-32.6983

Div&CapEx Cov

-32.6983

P/BV

-0.8603

P/B

-0.8603

P/S

0.5746

P/E

-0.7506

P/FCF

-1.7918

P/OCF

-1.9338

P/CF

-1.9338

PEG

-0.0075

P/S

0.5746

EV Multiple

-2.1133

P/FV

-0.8603

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation